J&J prostate cancer drug reduces risk of cancer spread and death in late-stage study

J&J prostate cancer drug reduces risk of cancer spread and death in late-stage study  Reuters

Summary aggregated from Reuters's public RSS feed. The full reporting belongs to Reuters — please read it on their site.